BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Cambridge Biotech Obsidian Launches With $49.5M Investment From Google, Takeda, Vertex, Amgen and Others

  The Series A was led by GV, with participation from AtlasVenture, Takeda Ventures, Vertex Ventures HC, Amgen Ventures, Alexandria Venture Investments, and ShangPharma Group.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Amgen Employees Evacuated From Thousand Oaks Facility

  The four wildfires in Southern California are affecting tens of thousands of people.

  December 6, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Ex-Employees Accuse Biotech Hedge Fund Founder of Toxic Sexual Harassment Culture

  According to the report, Isaly made lewd comments to female employees, subjected them to pornographic images and made “pervasive sexist comments.”

  December 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  How Cambridge Biotech Akcea Teaches Its 80 Employees to Put a Human Face on Illnesses

  The company wants staffers to get a taste of life with a super-rare metabolic disorder. An actual taste.

  December 6, 2017

   · 

  1 min read
• Policy

  FDA Slaps Warning on Bay Area’s Hand Biomechanics Lab for Failing to Disclose Serious Injury

  The firm failed to submit a report to the agency of a serious injury that may have been caused by one of the company’s medical devices.

  December 6, 2017

   · 

  1 min read
• 

  Business

  Amazon Yanks Pharma License App in Maine

  Amazon didn’t immediately respond to a request for comment.

  December 6, 2017

   · 

  1 min read
• 

  Policy

  Abbott Maintains Nanostim Leadless Pacemaker Halt on Docking Button Issue

  The 3.6mm docking button is designed to allow the Nanostim device to be retrieved after implantation.

  December 6, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About DMD Therapeutics

  DMD Therapeutics is based in Seattle, although at present it is a virtual company, and, as its name suggests, is focused on developing therapeutics for DMD.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About Fortis Therapeutics

  Fortis Therapeutics is focused on immuno-oncology, specifically on developing an ADC for multiple myeloma and late-stage prostate cancer, including both the adenocarcinoma and neuroendocrine types.

  December 6, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Bay Area’s Carmot Lands $240M+ R&D Tie-Up With Biotech Giant Amgen

  Under the deal, Carmot will use its lead-identification technology to identify and advance novel drug leads for Parkinson’s disease and other disease areas.

  December 6, 2017

   · 

  2 min read

   · 

  Mark Terry